Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
augmenting, blockade, certificate, checkpoint, chemotherapy, CPI, immunosuppressive, mature, Mol, NaN, par, prevention, professional, relocated, retroactively, Saleh, successor, Summit, synergistically, trilaciclib, underway, upcoming, Yan, Yang
Removed:
abstract, accurate, Allergy, arrangement, bid, blood, buy, cancelled, continuing, cooperative, CRADA, criteria, cure, customer, decline, delisted, delisting, difficult, discretion, distinct, enrolling, entitled, goal, Health, impair, Institute, iv, laboratory, NIAID, NIH, play, primary, proliferative, qualitative, requirement, role, Rule, sell, signaling, studied, suffer, tissue, transferred, work
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view